These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 10914504)
1. The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. Leuenroth SJ; Grutkoski PS; Ayala A; Simms HH J Leukoc Biol; 2000 Jul; 68(1):158-66. PubMed ID: 10914504 [TBL] [Abstract][Full Text] [Related]
2. Mcl-1 correlates with reduced apoptosis in neutrophils from patients with sepsis. Härter L; Mica L; Stocker R; Trentz O; Keel M J Am Coll Surg; 2003 Dec; 197(6):964-73. PubMed ID: 14644285 [TBL] [Abstract][Full Text] [Related]
3. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. Moulding DA; Akgul C; Derouet M; White MR; Edwards SW J Leukoc Biol; 2001 Nov; 70(5):783-92. PubMed ID: 11698499 [TBL] [Abstract][Full Text] [Related]
4. HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. Liu XH; Yu EZ; Li YY; Kagan E J Cell Biochem; 2006 Mar; 97(4):755-65. PubMed ID: 16229017 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of Mcl-1 is responsible for the blockage of TRAIL-induced apoptosis mediated by EGF/ErbB1 signaling pathway. Henson ES; Gibson EM; Villanueva J; Bristow NA; Haney N; Gibson SB J Cell Biochem; 2003 Aug; 89(6):1177-92. PubMed ID: 12898516 [TBL] [Abstract][Full Text] [Related]
6. [New face of antiapoptotic proteins. I. Protein Mcl-1]. Bednarek J; Wesierska-Gadek J; Kiliańska ZM Postepy Biochem; 2007; 53(3):228-38. PubMed ID: 18399351 [TBL] [Abstract][Full Text] [Related]
7. Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamide. Thallinger C; Wolschek MF; Maierhofer H; Skvara H; Pehamberger H; Monia BP; Jansen B; Wacheck V; Selzer E Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4185-91. PubMed ID: 15217956 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia selects for high-metastatic Lewis lung carcinoma cells overexpressing Mcl-1 and exhibiting reduced apoptotic potential in solid tumors. Koshikawa N; Maejima C; Miyazaki K; Nakagawara A; Takenaga K Oncogene; 2006 Feb; 25(6):917-28. PubMed ID: 16247470 [TBL] [Abstract][Full Text] [Related]
9. In vitro effect of recombinant human granulocyte colony-stimulating factor on canine neutrophil apoptosis. Oguma K; Sano J; Kano R; Watari T; Moritomo T; Hasegawa A Vet Immunol Immunopathol; 2005 Dec; 108(3-4):307-14. PubMed ID: 16029896 [TBL] [Abstract][Full Text] [Related]
10. Suppression of PMN apoptosis by hypoxia is dependent on Mcl-1 and MAPK activity. Leuenroth SJ; Grutkoski PS; Ayala A; Simms HH Surgery; 2000 Aug; 128(2):171-7. PubMed ID: 10922988 [TBL] [Abstract][Full Text] [Related]
11. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711 [TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP delays neutrophil apoptosis via stabilization of Mcl-1. Kato T; Kutsuna H; Oshitani N; Kitagawa S FEBS Lett; 2006 Aug; 580(19):4582-6. PubMed ID: 16876795 [TBL] [Abstract][Full Text] [Related]
13. Regulation of neutrophil apoptosis by Mcl-1. Edwards SW; Derouet M; Howse M; Moots RJ Biochem Soc Trans; 2004 Jun; 32(Pt3):489-92. PubMed ID: 15157168 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells. Clohessy JG; Zhuang J; Brady HJ Br J Haematol; 2004 Jun; 125(5):655-65. PubMed ID: 15147382 [TBL] [Abstract][Full Text] [Related]
16. Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Michels J; O'Neill JW; Dallman CL; Mouzakiti A; Habens F; Brimmell M; Zhang KY; Craig RW; Marcusson EG; Johnson PW; Packham G Oncogene; 2004 Jun; 23(28):4818-27. PubMed ID: 15122313 [TBL] [Abstract][Full Text] [Related]
17. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Gojo I; Zhang B; Fenton RG Clin Cancer Res; 2002 Nov; 8(11):3527-38. PubMed ID: 12429644 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Chetoui N; Sylla K; Gagnon-Houde JV; Alcaide-Loridan C; Charron D; Al-Daccak R; Aoudjit F Mol Cancer Res; 2008 Jan; 6(1):42-52. PubMed ID: 18234961 [TBL] [Abstract][Full Text] [Related]
19. High expression of Bcl-xL in delayed apoptosis of canine neutrophils induced by lipopolysaccharide. Sano J; Oguma K; Kano R; Yazawa M; Tsujimoto H; Hasegawa A Res Vet Sci; 2005 Apr; 78(2):183-7. PubMed ID: 15563927 [TBL] [Abstract][Full Text] [Related]
20. The three-substituted indolinone cyclin-dependent kinase 2 inhibitor 3-[1-(3H-imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one (SU9516) kills human leukemia cells via down-regulation of Mcl-1 through a transcriptional mechanism. Gao N; Kramer L; Rahmani M; Dent P; Grant S Mol Pharmacol; 2006 Aug; 70(2):645-55. PubMed ID: 16672643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]